Dr. Darrell Tan is an infectious diseases physician, clinician-scientist and Tier 2 Canada Research Chair whose research focuses on clinical trials in human immunodeficiency virus (HIV) prevention and HIV/sexual transmitted infection (STI) co-infection. He is Co-Lead of the Prevention Core within the CIHR Canadian HIV Trials Network (CTN), and is leading multiple efforts to optimize the implementation of HIV pre- and post-exposure prophylaxis (PrEP and PEP) in Canada. Additional research interests are in the interaction between HIV and common co-infections such as herpes simplex virus type 2 (HSV-2) and syphilis, and the role of systemic inflammation in driving clinical outcomes in individuals living with HIV.

For a list of Dr. Tan's publications, please visit PubMed.